ETF Managers Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

ETF Managers Group’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-22,190	Closed	-$569K	–	735
2021 Q2	$569K	Sell	22,190 -849	-4%	-$16.7K	0.01%	494
2021 Q1	$370K	Sell	23,039 -13,111	-36%	-$299K	0.01%	563
2020 Q4	$685K	Sell	36,150 -5,807	-14%	-$104K	0.02%	287
2020 Q3	$571K	Buy	+41,957	New	+$647K	0.02%	280

ETF Managers Group's TBIO Position: Q3 2021 in Review

ETF Managers Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 22,190 shares — an estimated $569K sold.

ETF Managers Group first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $685K in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

ETF Managers Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
ETF Managers Group sold 22,190 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $569K.
ETF Managers Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
ETF Managers Group's Translate Bio, Inc. Common Stock position peaked at $685K in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on ETF Managers Group's 13F filing for Q3 2021, filed 15 Nov 2021.